On June 1, 2020, the Canadian Patented Medicine Prices Review Board (PMPRB) announced that the coming into force date for the amended Patented Medicines Regulations (Regulations) will be delayed until January 1, 2021.
The amendments to the Regulations were previously set to come into force July 1, 2020, as was previously reported by the E-TIPS® Newsletter here. The Order in Council states that the reasoning for the delay is to:
- minimize the administrative burden on patented drug manufacturers that are currently dealing with increased demands for existing products and, potentially, new treatments and vaccines in response to COVID-19; and
- provide stakeholders a longer period to participate in the PMPRB Draft Guidelines consultation process, which has also been impacted by the COVID-19 pandemic.
In November 2019, the PMPRB released draft Guidelines for consultation. The draft Guidelines set out the PMPRB’s approach to the price review process and investigations. The PMPRB received over 120 written submissions in response to the consultation.
The PMPRB has also announced that revised draft Guidelines will be published for consultation later this week.
For more information on the PMPRB revised draft Guidelines consultation, please see the Government of Canada website here.
Summary By: Michelle Noonan
E-TIPS® ISSUE
Disclaimer: This Newsletter is intended to provide readers with general information on legal developments in the areas of e-commerce, information technology and intellectual property. It is not intended to be a complete statement of the law, nor is it intended to provide legal advice. No person should act or rely upon the information contained in this newsletter without seeking legal advice.
E-TIPS is a registered trade-mark of Deeth Williams Wall LLP.
